(INNS)
BURFIRALIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS VIM (VIMENTIN)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-445) [VH (HOMO SAPIENS IGHV1-2*06 (86.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.11] (26-33.51-58.97-107)) (1-118)-HOMO SAPIENS IGHG4*01 (100%) (CH1 (119-216), HINGE 1-12 (217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (119-445)], (132- 214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [VKAPPA (HOMO SAPIENS IGKV1-39*01 (85.3%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') - HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA(WHO)
BURFIRALIMABUM(INN)